CN Patent
CN116529241A — 治疗化脓性汗腺炎的方法
Assigned to Chemocentryx Inc · Expires 2023-08-01 · 3y expired
What this patent protects
本文提供了治疗患有嗜中性炎性皮肤病的受试者的方法,这些方法包括向有需要的受试者施用治疗有效量的具有式I的化合物或其药学上可接受的盐,其中每个可变位置如本文所定义。在一些实施例中,该嗜中性炎性皮肤病是化脓性汗腺炎(HS)。
USPTO Abstract
本文提供了治疗患有嗜中性炎性皮肤病的受试者的方法,这些方法包括向有需要的受试者施用治疗有效量的具有式I的化合物或其药学上可接受的盐,其中每个可变位置如本文所定义。在一些实施例中,该嗜中性炎性皮肤病是化脓性汗腺炎(HS)。
Drugs covered by this patent
- Tavneos (AVACOPAN) · Chemocentryx
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.